Protectin conjugates in tissue regeneration 1 alleviates sepsis-induced acute lung injury by inhibiting ferroptosis

被引:25
|
作者
Lv, Ya [1 ,2 ,3 ]
Chen, Deming [1 ,2 ,3 ]
Tian, Xinyi [1 ,2 ,3 ]
Xiao, Ji [5 ]
Xu, Congcong [2 ,3 ]
Du, Linan [2 ,3 ]
Li, Jiacong [6 ]
Zhou, Siyu [6 ]
Chen, Yuxiang [6 ]
Zhuang, Rong [1 ,2 ]
Gong, Yuqiang [1 ,2 ]
Ying, Binyu [1 ,2 ]
Gao-Smith, Fang [2 ,3 ,4 ]
Jin, Shengwei [1 ,2 ,3 ]
Gao, Ye [1 ,2 ,3 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anaesthesia & Crit Care, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 2, Key Lab Anesthesiol Zhejiang Prov, Wenzhou, Zhejiang, Peoples R China
[4] Univ Birmingham, Inst Inflammat & Ageing, Birmingham Acute Care Res Ctr, Birmingham, England
[5] Hunan Canc Hosp, Dept Anesthesiol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
[6] Wenzhou Med Univ, Sch Med 2, Wenzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
PCTR1; Ferroptosis; Sepsis; Acute lung injury; CREB; CELL-DEATH; INFLAMMATION; METABOLISM; INSIGHTS; FAILURE; CARE;
D O I
10.1186/s12967-023-04111-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundAcute lung injury (ALI) is a common and serious complication of sepsis with high mortality. Ferroptosis, categorized as programmed cell death, contributes to the development of lung injury. Protectin conjugates in tissue regeneration 1 (PCTR1) is an endogenous lipid mediator that exerts protective effects against multiorgan injury. However, the role of PCTR1 in the ferroptosis of sepsis-related ALI remains unknown.MethodsA pulmonary epithelial cell line and a mouse model of ALI stimulated with lipopolysaccharide (LPS) were established in vitro and in vivo. Ferroptosis biomarkers, including ferrous (Fe2+), glutathione (GSH), malondialdehyde (MDA) and 4-Hydroxynonenal (4-HNE), were assessed by relevant assay kits. Glutathione peroxidase 4 (GPX4) and prostaglandin-endoperoxide synthase 2 (PTGS2) protein levels were determined by western blotting. Lipid peroxides were examined by fluorescence microscopy and flow cytometry. Cell viability was determined by a CCK-8 assay kit. The ultrastructure of mitochondria was observed with transmission electron microscopy. Morphology and inflammatory cytokine levels predicted the severity of lung injury. Afterward, related inhibitors were used to explore the potential mechanism by which PCTR1 regulates ferroptosis.ResultsPCTR1 treatment protected mice from LPS-induced lung injury, which was consistent with the effect of the ferroptosis inhibitor ferrostatin-1. PCTR1 treatment decreased Fe2+, PTGS2 and lipid reactive oxygen species (ROS) contents, increased GSH and GPX4 levels and ameliorated mitochondrial ultrastructural injury. Administration of LPS or the ferroptosis agonist RSL3 resulted in reduced cell viability, which was rescued by PCTR1. Mechanistically, inhibition of the PCTR1 receptor lipoxin A4 (ALX), protein kinase A (PKA) and transcription factor cAMP-response element binding protein (CREB) partly decreased PCTR1 upregulated GPX4 expression and a CREB inhibitor blocked the effects ofPCTR1 on ferroptosis inhibition and lung protection.ConclusionThis study suggests that PCTR1 suppresses LPS-induced ferroptosis via the ALX/PKA/CREB signaling pathway, which may offer promising therapeutic prospects in sepsis-related ALI.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis
    Pengfei Liu
    Yetong Feng
    Hanwei Li
    Xin Chen
    Guangsuo Wang
    Shiyuan Xu
    Yalan Li
    Lei Zhao
    Cellular & Molecular Biology Letters, 2020, 25
  • [22] CCL25 Inhibition Alleviates Sepsis-Induced Acute Lung Injury and Inflammation
    Xia, Demeng
    Wang, Sheng
    Liu, Anwei
    Li, Lei
    Zhou, Panyu
    Xu, Shuogui
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 3309 - 3321
  • [23] Unfractionated Heparin Alleviates Sepsis-Induced Acute Lung Injury by Protecting Tight Junctions
    Liu, Yina
    Mu, Shengtian
    Li, Xu
    Liang, Yingjian
    Wang, Liang
    Ma, Xiaochun
    JOURNAL OF SURGICAL RESEARCH, 2019, 238 : 175 - 185
  • [24] Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats
    Xia, Wenfang
    Zhang, Huanming
    Pan, Zhou
    Li, Guang
    Zhou, Qingshan
    Hu, Dan
    Liu, Yu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 72 : 211 - 217
  • [25] Melatonin Attenuates Sepsis-Induced Acute Lung Injury via Inhibiting Excessive Mitophagy
    Ling, Jianmin
    Yu, Shanshan
    Xiong, Feng
    Xu, Tingting
    Li, Shusheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 2775 - 2786
  • [26] Gentiopicroside Ameliorates Sepsis-Induced Acute Lung Injury via Inhibiting Inflammatory Response
    Hu, Mu
    Du, Hangxiang
    Xu, Yang
    Wang, Yan
    CANADIAN RESPIRATORY JOURNAL, 2024, 2024
  • [27] Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation
    Zhang, Jin
    Wang, Changsong
    Wang, Hongliang
    Li, Xueting
    Xu, Jingjing
    Yu, Kaijiang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 95
  • [28] Sacubitril/valsartan alleviates sepsis-induced acute lung injury via inhibiting GSDMD-dependent macrophage pyroptosis in mice
    Wang, Jun
    Li, Jierui
    Lou, Anni
    Lin, Ying
    Xu, Qihan
    Cui, Wanfu
    Huang, Weichang
    Wang, Guozhen
    Li, Yang
    Sun, Jing
    Gong, Jiacheng
    Guo, Qiuping
    Qiu, Hongshen
    Meng, Ying
    Li, Xu
    FEBS JOURNAL, 2023, 290 (08) : 2180 - 2198
  • [29] Overexpression of Limb Bud and Heart Alleviates Sepsis-Induced Acute Lung Injury via Inhibiting the NLRP3 Inflammasome
    Wang, Yifan
    Shi, Yang
    Zhang, Xiaohong
    Fu, Jing
    Chen, Feng
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [30] Renqing Changjue alleviates sepsis-induced acute lung injury by regulating renin-angiotensin system and inhibiting inflammatory response
    Zhu, Minxia
    Lei, Yaqi
    Zhang, Zhaojun
    Guo, Xu
    Guo, Jing
    Wu, Ruipeng
    Li, Xiaofeng
    Tian, Shibo
    Zhao, Yuanhao
    IMMUNOBIOLOGY, 2025, 230 (03)